astellas pharma inc
(4503:Tokyo Stock Exchange)
Sef P. Kurstjens M.D., Ph.D.
Chief Medical Officer and President of Global Development,Astellas Pharma, Inc.
|Age||Total Calculated Compensation||This person is connected to 47 board members in 1 different organizations across 3 different industries.|
See Board Relationships
Dr. Sef P. Kurstjens, M.D., Ph.D. serves as Chief Medical Officer at Astellas Pharma Inc. Dr. Kurstjens has been the President of Astellas Pharma Global Development, Inc. since October 2013. Dr. Kurstjens serves as Chief Medical Officer of Astellas Pharma, Inc. Dr. Kurstjens served as the President and the Chief Executive Officer at Agensys, Inc. since November 2010. Dr. Kurstjens served as the Senior Vice President, Chief Medical Officer and Head, Global Drug Development ...
2-5-1, Nihonbashi-HonchoPhone: 81 3 3244 3000
Tokyo, -- 103-8411
Board Members Memberships*
Wits Medical School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Vincent A. Forlenza||Chairman, Chief Executive Officer, President and Chairman of Executive Committee|
Becton, Dickinson and Company
|Heather Bresch||Chief Executive Officer, Executive Director and Member of Science & Technology Committee|
|Michael F. Mahoney||Chief Executive Officer, President and Director|
Boston Scientific Corporation
|J. Michael Pearson||Chairman and Chief Executive Officer|
Valeant Pharmaceuticals International, Inc.
|Paul R. Perreault BA Psychology||Chief Executive Officer, Managing Director, Executive Director, Member of Innovation & Development Committee and Member of Securities & Market Disclosure Committee|
|$2.9M||Compensation as of Fiscal Year 2014.|